Robert Letterio Oliva - 19 Apr 2022 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role
Director
Signature
/s/ Christopher David, as Attorney-in-Fact for Robert Oliva
Issuer symbol
NVOS
Transactions as of
19 Apr 2022
Net transactions value
+$22,281
Form type
4
Filing time
21 Apr 2022, 16:05:42 UTC
Previous filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVOS Common Stock Purchase $11,125 +5,000 +2.4% $2.22 212,717 19 Apr 2022 Direct
transaction NVOS Common Stock Purchase $10,481 +4,700 +2.2% $2.23 217,417 20 Apr 2022 Direct
transaction NVOS Common Stock Purchase $675 +300 +0.14% $2.25 217,717 20 Apr 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.